...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Clinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advances
【24h】

Clinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advances

机译:慢性阻塞性肺疾病和哮喘的临床表型:最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma and chronic obstructive pulmonary disease (COPD) are prevalent obstructive lung diseases, both of which are characterized by airflow limitation. Although both represent distinct pathogenic entities, there can be significant clinical and physiologic overlap between the 2 disorders, creating potential management difficulties for clinicians. Although practice guidelines for both conditions outline diagnostic and management strategies, asthma and COPD are highly heterogeneous, and the symptoms of many patients remain poorly controlled despite adherence to current guidelines. Recent advances in phenotyping studies have elucidated heterogeneity in these airway diseases and might represent the best opportunity to enhance diagnosis, predict outcomes, and personalize treatments in patients with asthma and those with COPD. This review will focus on recent advances in describing phenotypic heterogeneity in asthma and COPD, including the evaluation of multiple clinical variables, molecular biomarkers, physiologic and radiologic data, and factors associated with disease progression and frequent exacerbations. ? 2013 American Academy of Allergy, Asthma & Immunology.
机译:哮喘和慢性阻塞性肺疾病(COPD)是普遍存在的阻塞性肺疾病,两者均以气流受限为特征。尽管两者都代表不同的病原体,但两种疾病之间可能在临床和生理上有重大重叠,给临床医生带来了潜在的管理困难。尽管针对这两种情况的实践指南都概述了诊断和管理策略,但哮喘和COPD的异质性很高,尽管遵守了当前指南,但许多患者的症状仍然难以控制。表型研究的最新进展已经阐明了这些气道疾病的异质性,可能代表了增强哮喘,COPD患者的诊断,预测结果和个性化治疗的最佳机会。这篇综述将侧重于描述哮喘和COPD表型异质性的最新进展,包括对多个临床变量,分子生物标志物,生理和放射学数据以及与疾病进展和频繁发作相关的因素进行评估。 ? 2013年美国过敏,哮喘和免疫学学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号